Teruaki Murakami
Suita, 5650871, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
CD147-high classical monocytes: a cellular biomarker for COVID-19 disease severity and treatment response.
Journal: Inflammation and regeneration
Published: January 22, 2025
Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients.
Journal: Life science alliance
Published: April 17, 2024
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 20, 2023
Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19.
Journal: Inflammation and regeneration
Published: October 14, 2022
Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in Japan.
Journal: The Lancet regional health. Western Pacific
Published: August 31, 2022
A case of Takayasu arteritis complicated with pulmonary infarction.
Journal: Oxford medical case reports
Published: July 21, 2022
Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells.
Journal: JCI insight
Published: July 06, 2022
The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus.
Journal: International immunology
Published: May 17, 2022
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity.
Journal: Nature genetics
Published: January 31, 2022
DOCK2 is involved in the host genetics and biology of severe COVID-19.
Journal: Nature
Published: October 26, 2021
Last Updated: 09/26/2026